|
Her kan du søge efter analysenavn, analysenummer eller IPAC.
1 |
| 1. grav.-us (blodtype), KIA |
| 1. grav.-us (blodtype,virus), KIA |
2 |
| 2. grav.-us (RhD neg), KIA |
A |
| Adalimumab monitorering, KIA |
| Adalimumab;P, KIA |
| Adalimumab-Ab;P, KIA |
| ANA (mønster, imm.flu.) gruppe;P, KIA |
| ANA (mønster, imm.flu.) gruppe;P - Titrering, KIA |
| Antistofscreentest, KIA |
B |
| BAC-test udløb;B, KIA |
| BF test udløb;P, KIA |
| Biologiske forprøver HBV,HCV,HIV, KIA |
| Blodprøver på børn, KIA |
| Blodtype(ABO; Rh D);Erc(B), KIA |
C |
| CD34 prognose, KIA |
D |
| Direkte antiglobulin gruppe;Erc(B) (DAT), KIA |
E |
| Erythrocyt D(Ag);Erc(B) (RhD-profylakse), KIA |
| Erythrocyt-(A;B)-Ab gruppe;P (Titer Anti-A/-B), KIA |
| Erytrocyt - Antistofidentifikation, KIA |
| Erytrocyt-Ab (kvant) gruppe;P (Titer gravid), KIA |
| Erytrocytter (HbF-holdige);Ercs(B), KIA |
| Etanercept monitorering, KIA |
| Etanercept;P, KIA |
| Etanercept-Ab;P, KIA |
F |
| Føtal AB0 prædiktion;(Ercs(Foster;B), KIA |
G |
| Golimumab monitorering, KIA |
| Golimumab;P, KIA |
| Golimumab-Ab;P, KIA |
H |
| HCV LIA, KIA |
| Hepatitis B virus - FØR VACC, KIA |
| Hepatitis B virus - KONTROL AF KENDT, KIA |
| Hepatitis B virus c-Ab [Anti-HBc];P, KIA |
| Hepatitis B virus c-IgM [HBc-IgM];P, KIA |
| Hepatitis B virus e(Ag) [HBeAg];P, KIA |
| Hepatitis B virus e-Ab [Anti-HBe];P, KIA |
| Hepatitis B virus s(Ag) [HBsAg];P, KIA |
| Hepatitis B virus s-Ab [Anti-HBs];P, KIA |
| Hepatitis B virus(DNA) (0 1) [HBV];P, KIA |
| Hepatitis B+C - Udredning, KIA |
| Hepatitis C virus(RNA) (0 1) [HCV];P, KIA |
| Hepatitis C virus-Ab [HCV-Ab];P, KIA |
| HIV 1+2 (Ag+Ab);P, KIA |
| HIV LIA, KIA |
| HLA klasse I-Ab, KIA |
| HLA klasse II-Ab, KIA |
| HLA-Antistof, KIA |
| HLA-B-gen (B27);DNA, KIA |
| HLA-B-gen (B51);DNA, KIA |
| HLA-B-gen (B5701);DNA, KIA |
| HLA-DQB1-genDQB1*06:02;DNA, KIA |
| HLA-klasse I(Ag) gruppe;Lkc(B), KIA |
| HLA-klasse II(Ag) gruppe;Lkc(B), KIA |
| Human imm.defektvirus 1+2(RNA);(0 1), KIA |
| Hæmatopoietiske stamceller;B, KIA |
| Hæmolysiner (bifasisk);P, KIA |
I |
| Infliximab monitorering, KIA |
| Infliximab;P, KIA |
| Infliximab-Ab;P, KIA |
K |
| KMT-PT familieundersøgelse: 1.us., KIA |
| KMT-pt.: 1.us., KIA |
| KMT-pt.: 2.us., KIA |
| KMT-pt.:forus., KIA |
| KMT-pt´s udvalgt familiedonor: 2.us, KIA |
| KMT-pt's udvalgt fam. donor: forus., KIA |
| Kuldeagglutinin;P, KIA |
M |
| Mannosebindende lektin;P, KIA |
| MBL2-gen;DNA, KIA |
| Multiplate standard 1 - Trombocytaggregometri, KIA |
| Mærkning af blodprøver og rekvisition, KIA |
N |
| NAT (HIV,HBV,HCV), KIA |
| Nyre-pt.: 1. us., KIA |
| Nyre-pt.: 2. us., KIA |
O |
| Opfølgende blodtypeanalyser, KIA |
P |
| Prisoversigt Klinisk Immunologisk Afdeling, ØI |
R |
| Refraktær trombocytopeni, KIA |
| RHD-gen;DNA - Antenatal genotypning, KIA |
S |
| Stikskade, indekspatient, KIA |
| Stikskade, skadesramt, 2 mdr., KIA |
| Stikskade, skadesramt, dag 0, KIA |
T |
| T-/B-/NK-lymfocytter;B, KIA |
| Thrombocyt (HPA)-Ab gruppe;P, KIA |
| T-Lymfocytter(CD4,CD8);B, KIA |
| Transfusionskomplikation, KIA |
| Treponema pallidum-Ab;P, KIA |
| Trombocyt-gentypebestemmelse, (HPA), KIA |
| Tromboelastometri (ROTEM), KIA |
U |
| Urokinase plasminogen activator surface receptor(soluble), KIA |
V |
| Vir prøve til imm. gravid, KIA |
| VIRUS-US - KØNSCELLE EJ PARTNER, KIA |
| VIRUS-US - KØNSCELLE TIL PARTNER, KIA |
| VIRUS-US - STAMCELLEDONOR, KIA |
| VIRUS-US - VÆVSDONOR ALLOGEN, KIA |
| Vævstypebestemmelse (HLA typebestemmelse), KIA |
|
|
